VitalRhythm vs Zio AT ECG Monitoring System

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by VitalConnect
VS
by iRhythm Technologies, Inc.

AI Verdict

Both VitalRhythm and Zio AT are highly comparable AI-powered, FDA-cleared, cloud-based systems for continuous cardiac arrhythmia detection using wearable biosensors. While VitalRhythm emphasizes continuous ECG analysis for remote patient monitoring, Zio AT specifically highlights its mobile cardiac telemetry (MCT) service with up to 14 days of continuous recording and real-time data transmission. The choice between them may depend on the desired monitoring duration, real-time data needs, and the specific features of their respective clinician and patient platforms.

Choose VitalRhythm if…

Choose VitalRhythm if your primary need is continuous, cloud-based AI monitoring for cardiac arrhythmias, supporting remote patient management and non-urgent clinical decision-making. This tool excels in providing healthcare professionals with detected arrhythmia data for review via a web application, integrating seamlessly with the VitalPatch biosensor for extended surveillance.

View VitalRhythm →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT if you require a comprehensive mobile cardiac telemetry (MCT) service with real-time data transmission for up to 14 days of continuous ECG monitoring. This system is ideal for detecting both symptomatic and asymptomatic cardiac events, providing clinicians with detailed, AI-powered end-of-wear reports for definitive diagnosis and treatment planning.

View Zio AT ECG Monitoring System →

When choosing between VitalRhythm and the Zio AT ECG Monitoring System, physicians should consider their primary need for continuous cardiac arrhythmia detection and the practical differences in their integrated hardware and service models.

VitalRhythm, integrating with the VitalPatch biosensor, excels in continuous, cloud-based AI analysis of ECG signals for various arrhythmias. It is best suited for practices prioritizing a proprietary wearable biosensor system with real-time data display via the VistaCenter web application, supporting non-urgent clinical decision-making and remote patient monitoring. Physicians seeking a system that offers direct integration with a specific biosensor for ongoing monitoring and review by their own staff may find VitalRhythm more aligned with their workflow.

In contrast, the Zio AT ECG Monitoring System provides a comprehensive mobile cardiac telemetry (MCT) service. Its strength lies in its FDA-cleared deep-learned AI algorithm (ZEUS System) for continuous, uninterrupted ECG recording for up to 14 days, coupled with comprehensive end-of-wear reports. The key practical difference is that Zio AT is offered as a service, including the wearable patch, real-time data transmission, and detailed reporting, which may be beneficial for physicians who prefer an outsourced model for long-term arrhythmia detection and analysis, minimizing internal resource allocation for data interpretation and report generation.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature VitalRhythm Zio AT ECG Monitoring System
Pricing Contact for quote Contact for pricing
Deployment Cloud-based Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Tool B demonstrates a strong focus on patient-centered design, including a dedicated patient mobile app for symptom logging and education, and specific efforts to simplify at-home application for a broad user base. This comprehensive approach to patient and clinician experience, including design for a 'tech adverse population,' gives it an edge in overall usability.

Clinical Value

Zio AT ECG Monitoring System

Tool B has a more extensive and publicly documented clinical validation, with over 100 scientific publications demonstrating its value in long-term continuous monitoring and improved arrhythmia detection compared to traditional methods. Its ability to provide up to 14 days of uninterrupted recording and comprehensive end-of-wear reports offers significant clinical advantages for diagnosing elusive arrhythmias.

Pricing & Value

Zio AT ECG Monitoring System

While both tools require direct contact for pricing, Tool B offers greater transparency regarding its pricing model, including specific CPT codes for billing, broad insurance coverage (Medicare and major commercial plans), and various patient financial assistance programs. This detailed information, along with studies suggesting cost-effectiveness, provides a clearer understanding of its financial value.

Enterprise Readiness

Tie

Both tools demonstrate strong foundational enterprise readiness with cloud-based deployment, FDA clearance, HIPAA compliance, and BAA availability. While Tool A lists a broader range of specialties, Tool B explicitly mentions EHR integration, a critical feature for seamless enterprise workflow, making it difficult to definitively choose a winner without further details on the depth of integration or multi-specialty deployment specifics.

Innovation

Zio AT ECG Monitoring System

Tool B demonstrates a slightly higher degree of innovation through its comprehensive mobile cardiac telemetry (MCT) service, including a wireless gateway for real-time data transmission and a dedicated patient mobile app for enhanced engagement. Its pioneering role as an 'industry leader that first identified and met the need for long-term continuous monitoring' and user-centered design for at-home application further highlight its innovative approach.

Support & Docs

Zio AT ECG Monitoring System

Tool B offers a more comprehensive and transparent support system, including dedicated customer care, a specialized 24/7/365 billing team, and extensive FAQs and manuals for both patients and healthcare professionals. This indicates a stronger commitment to user support and documentation compared to Tool A's more general offerings of instructions and videos.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature VitalRhythm Zio AT ECG Monitoring System
Tool Name VitalRhythm Zio AT ECG Monitoring System
Company VitalConnect iRhythm Technologies, Inc.
Core Function AI-powered cloud-based software for continuous cardiac arrhythmia detection and analysis Continuous, AI-powered ECG monitoring for long-term arrhythmia detection
Wearable Component VitalPatch biosensor Wearable Zio AT patch
Monitoring Duration Not specified up to 14 days
Clinician Portal/Reporting Displays detected arrhythmias for review by healthcare professionals via VistaCenter web application ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation; Comprehensive end-of-wear reports
Patient App Not specified MyZiou00ae patient mobile app for symptom logging and education

Videos

Demos, reviews, and walkthroughs featuring VitalRhythm and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

VitalRhythm offers continuous cardiac arrhythmia detection and analysis, integrating with the VitalPatch biosensor for remote patient monitoring. Zio AT provides continuous, uninterrupted ECG recording for up to 14 days via a wearable patch and utilizes mobile cardiac telemetry (MCT) for real-time data transmission.
VitalRhythm detects various cardiac arrhythmias, including atrial fibrillation, AV block, supraventricular tachycardia, ventricular tachycardia, and pauses. Zio AT is designed for the detection of symptomatic and asymptomatic cardiac events and general arrhythmia detection, with its algorithm capable of classifying a broad range of arrhythmias.
VitalRhythm displays detected arrhythmias for review by healthcare professionals via its VistaCenter web application and supports non-urgent clinical decision-making. Zio AT provides comprehensive end-of-wear reports for clinicians and offers the ZioSuite clinician portal and mobile app for patient management and report interpretation.
Zio AT includes the MyZio patient mobile app for symptom logging, educational content, and reminders. VitalRhythm supports remote patient monitoring capabilities, but the provided information does not explicitly mention a dedicated patient mobile app for symptom logging or education.
VitalRhythm is applicable across Cardiology, Hospital Medicine, and Internal Medicine. Zio AT is specifically listed for Cardiology, though its use can be relevant for patients with transient symptoms often seen in broader internal medicine.
Zio AT utilizes a wireless gateway for real-time data transmission from its wearable patch to the iRhythm monitoring center. VitalRhythm analyzes ECG data and RR-intervals transmitted securely via the VitalPatch biosensor and Vista Solution platform for continuous monitoring.
VitalRhythm utilizes a proprietary deep learning-based algorithm for continuous ECG signal analysis and arrhythmia detection. Zio AT employs an FDA-cleared deep-learned AI algorithm known as the ZEUS System for arrhythmia detection and classification.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.